Sernova Biotherapeutics Inc
SEOVF
$0.1219
$0.00141.16%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 33.69% | -10.14% | 33.90% | 24.88% | -1.54% |
| Total Depreciation and Amortization | 0.00% | -73.16% | 4.96% | 56.86% | -1.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.06% | 216.53% | -177.80% | 5.52% | -2.53% |
| Change in Net Operating Assets | -731.87% | -92.53% | -53.46% | 63.99% | -59.60% |
| Cash from Operations | 20.51% | -18.18% | -12.93% | 52.29% | -69.52% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | 24.86% | 91.40% |
| Cash from Investing | -- | -- | -100.00% | 24.86% | 91.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.88% | -1.19% | 0.00% | 0.00% | 2.55% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | 125.56% | -470.61% | -64.56% | -- |
| Cash from Financing | 20,638.22% | -99.56% | 18,657.81% | -84.38% | 484.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 116.44% | -564.87% | -37.02% | 151.02% | -38.15% |